title: Encouraging efficacy of modern conformal fractionated radiotherapy in patients with uncured Cushing's disease.
abstract: The objective of this study was to assess the efficacy of modern conformal fractionated radiotherapy (RT) in patients with uncured Cushing's disease (CD) after failed transsphenoidal surgery (TSS). In this retrospective analysis, we reviewed records of patients with CD who received modern conformal fractionated RT between 2001 and 2010. Records were evaluated for frequency and interval of remission post RT. The change in the tumour size, endocrine insufficiencies and complications developing post RT were noted. Remission was defined as 2 mg Low dose dexamethasone suppressed cortisol of <50 nmol/l. During the study period of 10 years, a total of 24 patients (mean age: 27.9, range: 21-48 years) underwent pituitary RT for CD. Out of these, long term follow up was available for 22 patients and 20 patients (15F/5M, 12 microadenomas/8 macroadenomas) were included for final analysis. All the patients received modern conformal fractionated external beam RT (45 Gy in 25 fractions) with the median follow up of 37.5 months (range 12-144). Fifteen patients (10 microadenomas/5 macroadenomas) underwent remission after a median follow up period of 20 months. None of the patients had recurrence. Post RT, new onset endocrine deficiencies were seen in 8 (40 %) patients. Modern conformal fractionated external beam radiotherapy is an effective modality for treatment of adult patients with CD after failed TSS.
authors: Department of Endocrinology, Seth G S Medical College, KEM Hospital, Parel, Mumbai, 400012, Maharashtra, India, swetabudyal@gmail.com.
authors: Sweta
authors: S
authors: Budyal
authors: Anurag R
authors: AR
authors: Lila
authors: Rakesh
authors: R
authors: Jalali
authors: Tejpal
authors: T
authors: Gupta
authors: Rajeev
authors: R
authors: Kasliwal
authors: Varsha S
authors: VS
authors: Jagtap
authors: Tushar
authors: T
authors: Bandgar
authors: Padmavathy
authors: P
authors: Menon
authors: Nalini S
authors: NS
authors: Shah
mesh_terms: D000328:Adult; D003907:Dexamethasone; D019583:Dose Fractionation, Radiation; D005260:Female; D006801:Humans; D007018:Hypopituitarism / Q000209:etiology; D008297:Male; D008875:Middle Aged; D047748:Pituitary ACTH Hypersecretion / Q000532:radiotherapy* / Q000601:surgery; D010911:Pituitary Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D012074:Remission Induction; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D003907:Dexamethasone
references: J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62
references: 18413427
references: Radiother Oncol. 2005 Jan;74(1):37-44
references: 15683667
references: Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1
references: 18797356
references: J Clin Endocrinol Metab. 2005 Feb;90(2):800-4
references: 15562021
references: J Neurooncol. 2007 Aug;84(1):79-84
references: 17356896
references: J Neurosurg. 2002 Dec;97(5 Suppl):422-8
references: 12507068
references: J Clin Endocrinol Metab. 1995 Nov;80(11):3114-20
references: 7593411
references: Radiother Oncol. 1996 Oct;41(1):45-53
references: 8961367
references: J Clin Endocrinol Metab. 2008 Feb;93(2):358-62
references: 18056770
references: J Clin Endocrinol Metab. 2004 Dec;89(12):6348-57
references: 15579802
references: Neurosurgery. 2001 Aug;49(2):284-91; discussion 291-2
references: 11504104
references: Radiother Oncol. 2009 Dec;93(3):597-601
references: 19900729
references: Eur J Endocrinol. 2007 Feb;156(2):233-9
references: 17287413
references: Stereotact Funct Neurosurg. 1991;57(1-2):22-35
references: 1808652
references: Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):974-9
references: 19864079
references: J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609
references: 21602453
references: N Engl J Med. 1997 Jan 16;336(3):172-7
references: 8988897
references: J Neurosurg. 2000 Nov;93(5):738-42
references: 11059652
references: J Clin Endocrinol Metab. 1996 Jul;81(7):2647-52
references: 8675592
references: Clin Endocrinol (Oxf). 1999 Jul;51(1):61-6
references: 10468966
references: J Clin Endocrinol Metab. 2008 Feb;93(2):393-9
references: 18029460
references: J Neurosurg. 2003 May;98(5):967-73
references: 12744355
references: Neurosurg Clin N Am. 1999 Apr;10(2):327-36
references: 10099097
references: Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):333-41
references: 15890572
references: J Neurosurg. 2007 Jun;106(6):980-7
references: 17564168
references: Clin Endocrinol (Oxf). 1990 Oct;33(4):445-55
references: 2225489
references: J Neurosurg. 1994 Jan;80(1):37-45
references: 8271020
references: Acta Neurochir Suppl. 1996;65:31-4
references: 8738490
references: J Clin Endocrinol Metab. 1992 Sep;75(3):935-42
references: 1517389
references: Stereotact Funct Neurosurg. 2004;82(5-6):254-62
references: 15665560
references: Eur J Endocrinol. 2007 Jan;156(1):91-8
references: 17218730
references: J Neurosurg. 2009 Sep;111(3):531-9
references: 19267526